Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature

Pancreatic ductal adenocarcinoma (PDAC) has long been associated with low survival rates. A lack of accurate diagnostic tests and limited treatment options contribute to the poor prognosis of PDAC. Radioimmunotherapy using α- or β-emitting radionuclides has been identified as a potential treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hull, Ashleigh, Li, Yanrui, Bartholomeusz, Dylan, Hsieh, William, Allen, Barry, Bezak, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072553/
https://www.ncbi.nlm.nih.gov/pubmed/32092952
http://dx.doi.org/10.3390/cancers12020481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072553/
https://www.ncbi.nlm.nih.gov/pubmed/32092952
http://dx.doi.org/10.3390/cancers12020481

Ejemplares similares